Showing results (121-130 of 152) with videos related to

Sort By:
Pageof 16
Future Oncology (London, England)|April 14, 2026
Saruparib in combination with androgen receptor pathway inhibitors in metastatic hormone-sensitive prostate cancer: EvoPAR-Prostate01Arun A Azad, Neeraj Agarwal, Andrew J Armstrong, et al.
European Urology Open Science|November 11, 2025
Efficacy and Safety of Xialiqi for the Treatment of Benign Prostatic Hyperplasia in a Randomized TrialFeiya Yang, Chao Yang, Xin Wang, et al.
Cancer Immunology, Immunotherapy : CII|July 23, 2025
A multifunctional T-cell engager containing CD80 enhances prostate cancer treatmentDisen Nie, Yao Jiang, Hui Li, et al.
Ebiomedicine|June 25, 2025
High-resolution transcriptome atlas of bladder cancer highlights the functional myeloid subsets in modulating immune microenvironmentJiachen Liu, Zhen Shi, Yajian Li, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|November 9, 2022
Initial experience with 161 extraperitoneal laparoscopic radical cystectomy procedures: Comparison with transabdominal laparoscopic radical cystectomyHan Yang, Zongliang Zhang, Kai Zhao, et al.
Urology|November 17, 2022
Initial Experience With Extraperitoneal Laparoscopic Radical Cystectomy With Pelvic Organ-Preserving and Orthotopic Neobladder Techniques for Bladder Cancer in Female PatientsHan Yang, Zongliang Zhang, Kai Zhao, et al.
Cancer Management and Research|July 2, 2020
Efficacy and Safety of Androgen-Deprivation Therapy Combined with Docetaxel Plus Prednisone in High-Burden Metastatic Hormone-Sensitive Prostate CancerLinjun Hu, Qinxin Zhao, Hongsong Bai, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 12, 2024
The impact of integrating PRIMARY score or SUVmax with MRI-based risk models for the detection of clinically significant prostate cancerShikuan Guo, Jing Ren, Qingze Meng, et al.
Advanced Healthcare Materials|October 13, 2024
Targeting Hypoxia and Autophagy Inhibition via Delivering Sonodynamic Nanoparticles With HIF-2α Inhibitor for Enhancing Immunotherapy in Renal Cell CarcinomaYihao Zhu, Yajian Li, Xuwen Li, et al.
Chinese Medical Journal|August 23, 2024
Preliminary clinical practice of radical prostatectomy without preoperative biopsyRanlu Liu, Lu Yin, Shenfei Ma, et al.
Pageof 16